4Virdis, Agostino, Sehifrin, et al. Vascular inflammation : a role in vascular disease in hypertension [ J ]. Current pinion in Nephrology and Hypertension, 2003,12 ( 2 ) : 181.
5Ichtlseherer S, Rosenherer G, Dirk H, et al. Elevated C reactive prorein levels and impaired endothelial vasoreactivity in patients with coronary artery disease[ J]. Circulation ,2000,102( 13 ) : 1000.
6Bhagat K, Vallanee P. Inflammatory cytokines impair endothelium dependent dilation in human veins in vivo[ J]. Cireulation, 1997,96 (1): 3042.
7Yasunari K, Maeda K, Nakamura M,et al. Oxidative stress in leukocytes is a possible link between blood glucose,and C reactive protein [J]. Hypertension, 2002, 39( 1 ) : 777.
8Asher J, Houston M. Statins and C - reactive protein levels[ J ]. Clin Hypertens( Greenwich), 2007, 9 (8) : 622.
9Ahmet Yildiz,Akif Cakar, Murat Baskurt, et al. The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease [ J ]. Cardiovascular Ultrasound,2007,30 (5) : 51.
10Ge CJ,Lu SZ,Chen YD,et al. Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C -reactive protein in hypertensive patients with primary hypercholesterolemia[ J 1. Heart Vessels, 2008, 23 ( 2 ) : 91.
7Marrin M. Curent recommendation for the treatment of hypert ensin. Are they still yalid [ J ]. Hypertens, 2002,20 (1) :3 -10.
8Badr K,Wainwright CL.Inflammation in the cardiovascular system:here,there and everywhere[J].Curr Opin Pharmacol,2004;4:107-9
9Ridker PM,Buring JE,Shih J,Matias M,Hennekens CH.Prospectivestudy of C-reactive protein and the risk of future cardiovascular eventsamong apparently healthy women[J].Circulation,1998;98:731-3
10Pradhan AD,Manson JE,Rifai N,Buring JE,Ridker PM.C-reactiveprotein,IL 6,and risk of developing type 2 diabetes mellitus[J].JAMA Assoc,2001;286:327-34
9Viljoen A. New approaches in the diagnosis of atherosclero- sis and treatment of cardiovascular disease [ J ]. Recent Pat Cardiovasc Drug Discov,2008,3 ( 2 ) : 84 - 91.
10Nicholls SJ, Borgman M, Nissen SE, et al. Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN) [ J ]. Curr Med Res Opin,2011,27(6) :1 119 -1 129.
